Filing Flows › Innovate (VATE) › Stock forecast & fair value
Innovate (VATE) stock forecast and fair value
Innovate (VATE) trades at $5.26. Across 18 valuation methods the middle fair value is $136.13 (26×); the DCF says $192.00.
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| Regime-switching Monte Carlo 10th–90th | $10.07 | $228.96 | $1,593.44 | 44× |
| DCF — Monte Carlo 10th–90th percentile | −$2.44 | $192.00 | $482.74 | 37× |
| EV/EBITDA vs peers | $35.85 | $45.94 | $65.52 | +773% |
| EV/EBITDA vs peers, weighted | $41.50 | $49.60 | $96.51 | +843% |
| EV/EBITDA vs peers, growth-adjusted | $50.37 | $66.90 | $86.47 | 13× |
| EV/Sales vs peers | $109.33 | $193.15 | $290.87 | 37× |
| EV/Sales vs peers, weighted | $131.47 | $230.96 | $522.59 | 44× |
| EV/Sales vs peers, growth & margin adjusted | $100.02 | $160.58 | $247.42 | 31× |
| Outside view — base-rate Monte Carlo | −$194.49 | $23.99 | $310.82 | +356% |
| Owner earnings capitalized | $4.47 | $4.89 | $5.39 | -7% |
Innovate's latest quarter
Innovate, Q2 2026: revenue $422M (+74% year over year), operating margin 8.2%, net earnings $10.7M, operating cash flow −$24.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Innovate's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $1.51 and $300.45, with a middle value of $136.13 against a price of $5.26. Each method's assumptions are on the page.
Does Innovate usually beat earnings estimates?
It beat the consensus EPS estimate in 75% of the quarters on record.
Is VATE stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.